Regulatory And Cost Barriers Are Likely To Limit Biosimilar Development And Expected Savings In The Near Future


Autoria(s): Grabowski, HG; Guha, R; Salgado, M
Data(s)

01/06/2014

Formato

1048 - 1057

Identificador

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000338187200017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=47d3190e77e5a3a53558812f597b0b92

HEALTH AFFAIRS, 2014, 33 (6), pp. 1048 - 1057

0278-2715

http://hdl.handle.net/10161/12741

Relação

HEALTH AFFAIRS

10.1377/hlthaff.2013.0862

Tipo

Journal Article